Dr. Belov’s Lab NIH R21 Grant (2020-2022)

Dr. Belov's Lab

October 7, 2020

Congratulations Dr. Belov’s Lab NIH R21 Grant (2020-2022)

I am glad to inform you Dr. Belov's lab has received a new NIH R21 grant (2020-2022), Refocusing the immune response from structural to conserved non-structural proteins as a novel vaccination approach for inducing broad anti-enterovirus protection. Within this R21 grant, Dr. Belov and his collaborators will explore an innovative approach to developing anti-enterovirus vaccines.  Congratulations, Dr. Belov.